Company news
Resverlogix Corp. news in 2022
Resverlogix Corp.'s news releases, calls and decks from 2022, newest first.
InvestmentPitch Media Video Discusses Resverlogix' Enrollment and Dosing of Patients in a Phase 2b Clinical Trial at a Site at the University of Alberta Hospital in Edmonton, to evaluate Apabetalone as a Potential Oral Treatment for COVID-19 - Video Available on Investmentpitch.com
January 19, 2022
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
January 18, 2022